Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
714 participants
OBSERVATIONAL
2018-11-06
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be assigned a unique study number to protect the confidentiality of their personal health care information. All study data will be de-identified and then stored in a secure information management system, hosted at the study sponsor, Optimum Patient Care Global Limited in Cambridge, United Kingdom. Participant identities will always be kept confidential and will not be included in any research that is published. Data collected across the Canadian sites will be used to find ways to improve asthma treatments in Canada, to report on current patterns of managing severe asthma in Canada, to identify different sub-groups of severe asthma, and to carry out various medical research to understand asthma better and develop new treatments.
Research records and health or other source records may be inspected in the presence of the Principal Investigator or by representatives of the University of British Columbia's Clinical Research Ethics Board for the purpose of monitoring the research. No information or records that disclose participants' identities will be published without subject consent, nor will any information or records that disclose participants' identities be removed or released without subject consent unless required by law.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Severe Asthma Participants
Participants with severe asthma classified at GINA Step 4 and uncontrolled in terms of their symptoms and exacerbations or GINA Step 5.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants receiving treatment according to GINA Step 5 or uncontrolled in GINA Step 4 (uncontrolled is defined as having severe asthma symptoms or frequent exacerbations)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alberta
OTHER
University of Toronto
OTHER
Laval University
OTHER
McGill University
OTHER
Université de Sherbrooke
OTHER
The Ottawa Hospital
OTHER
Queen's University
OTHER
University of Saskatchewan
OTHER
Western University, Canada
OTHER
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Celine Bergeron
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Celine Bergeron
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alberta
Edmonton, Alberta, Canada
Synergy MD Specialty Group
Edmonton, Alberta, Canada
University of British Columbia
Vancouver, British Columbia, Canada
University of British Columbia
Vancouver, British Columbia, Canada
Kingston General Hospital
Kingston, Ontario, Canada
University of Western Ontario
London, Ontario, Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
Inspiration Research Limited
Toronto, Ontario, Canada
McGill University
Montreal, Quebec, Canada
Université de Sherbrooke
Sherbrooke, Quebec, Canada
Université Laval
Quebéc City, Quebéc, Canada
University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Amy Haarsma
Role: primary
Carrie McPhee
Role: primary
Shelley Abercromby
Role: primary
Leiana Hoshyari
Role: primary
Alison Morra
Role: primary
Hana Serajeddini
Role: primary
Kathy Vandemheen
Role: primary
Kayla Cardoso
Role: primary
Cathy Fugere
Role: primary
Martine Duval
Role: primary
Marie-Eve Boulay
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H17 - 03052
Identifier Type: -
Identifier Source: org_study_id